# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-18-000010
Filing Date
2018-04-24
Accepted
2018-04-24 16:53:10
Documents
123
Period of Report
2018-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2018331x10q.htm | 10-Q | 1675257
2 | EXHIBIT 10.1 | biib-2018331xex101.htm | EX-10.1 | 26928
3 | EXHIBIT 10.2 | biib-2018331xex102.htm | EX-10.2 | 26718
4 | EXHIBIT 10.3 | biib-2018331xex103.htm | EX-10.3 | 24843
5 | EXHIBIT 10.4 | biib-2018331xex104.htm | EX-10.4 | 33411
6 | EXHIBIT 31.1 | biib-2018331xex311.htm | EX-31.1 | 14189
7 | EXHIBIT 31.2 | biib-2018331xex312.htm | EX-31.2 | 14917
8 | EXHIBIT 32.1 | biib-2018331xex321.htm | EX-32.1 | 10758
15 |  | acquirediprd.jpg | GRAPHIC | 14530
16 |  | amortacqintanassets.jpg | GRAPHIC | 16571
17 |  | anticd20therapeuticprograms.jpg | GRAPHIC | 35517
18 |  | biogenlogostandarda12.jpg | GRAPHIC | 756402
19 |  | biogenlogostandarda15.jpg | GRAPHIC | 756402
20 |  | biosimilars.jpg | GRAPHIC | 18267
21 |  | collabprofitshare.jpg | GRAPHIC | 16183
22 |  | costofsales.jpg | GRAPHIC | 23076
23 |  | financialhighlights.jpg | GRAPHIC | 37670
24 |  | gainlossonfvcontcons.jpg | GRAPHIC | 15768
25 |  | incometaxprovision.jpg | GRAPHIC | 24716
26 |  | interferon.jpg | GRAPHIC | 24973
27 |  | oie.jpg | GRAPHIC | 16375
28 |  | otherrevenues.jpg | GRAPHIC | 22115
29 |  | rd.jpg | GRAPHIC | 56824
30 |  | rdpiechart2017.jpg | GRAPHIC | 35840
31 |  | rdpiechart2018.jpg | GRAPHIC | 36645
32 |  | reserves.jpg | GRAPHIC | 28135
33 |  | restructuring.jpg | GRAPHIC | 15363
34 |  | sga.jpg | GRAPHIC | 16979
35 |  | spinraza.jpg | GRAPHIC | 23540
36 |  | tecfidera.jpg | GRAPHIC | 27462
37 |  | tysabri.jpg | GRAPHIC | 25152
38 |  | zinbryta.jpg | GRAPHIC | 17117
| Complete submission text file | 0000875045-18-000010.txt |  | 12500642

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE DOCUMENT | biib-20180331.xml | EX-101.INS | 2355852
10 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20180331.xsd | EX-101.SCH | 68072
11 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20180331_cal.xml | EX-101.CAL | 102757
12 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20180331_def.xml | EX-101.DEF | 326228
13 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20180331_lab.xml | EX-101.LAB | 845454
14 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20180331_pre.xml | EX-101.PRE | 508645

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 18771947
SIC: 2836 Biological Products, (No Diagnostic Substances)